- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioGaia AB ser. B (BIOGb)
The BioGaia B share price today is 118.7, view ST BIOGb stock exchange data. Track the latest BioGaia B share price with real-time updates on BIOGb stock performance including market cap, day range, 52-week range and dividend yield. Access BIOGb charts, earnings dates and analyst estimates to support your investment decisions.
118.7
+0.8(+0.68%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
117.0
119.4
52 wk Range
93.2
124.0
Earnings results expected in 4 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
117.0119.4
52 wk Range
93.2124.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.37%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.37%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIOGb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
140.0
Upside
+17.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 140.0
(+17.94% Upside)
Earnings
Latest Release
12-02-2026
EPS / Forecast
0.98 / 0.82
Revenue / Forecast
441M / 388.93M
Compare BIOGb to Peers and Sector
Metrics to compare | BIOGb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOGbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.1x | 20.9x | −0.5x | |
PEG Ratio | −6.70 | 2.21 | 0.00 | |
Price/Book | 9.1x | 7.3x | 2.6x | |
Price / LTM Sales | 7.8x | 5.0x | 3.2x | |
Upside (Analyst Target) | 17.9% | 2.3% | 48.1% | |
Fair Value Upside | Unlock | 9.3% | 6.6% | Unlock |
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BioGaia B (BIOGb) Share Price Today?
The BioGaia B share price today is 118.7.
What is the current BioGaia B (BIOGb) share price and day range?
As of 03-05-2026, the BioGaia B share price is 118.7, with a previous close of 117.9. The share price has ranged from 117.0 to 119.4 today, while the 52-week range spans from 93.2 to 124.0.
What Is the BioGaia B Market Cap?
As of today, BioGaia B market cap is 12.01B.
Does BioGaia B Pay Dividends? What's The Current Dividend Yield?
The BioGaia B dividend yield is 3.37%.
What Is the BioGaia B (BIOGb) Share Price Target?
The average 12-month share price target for BioGaia B is 140.0, with a high estimate of 140 and a low estimate of 140. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +17.94% Upside potential.
What Is BioGaia B's Earnings Per Share (TTM)?
The BioGaia B EPS (TTM) is 3.3.
When Is the Next BioGaia B Earnings Date?
BioGaia B will release its next earnings report on 07-05-2026.
From a Technical Analysis Perspective, Is BIOGb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does BioGaia B Trade On?
BioGaia B is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for BioGaia B?
The stock symbol for BioGaia B is "BIOGb."
How Many Times Has BioGaia B Stock Split?
BioGaia B has split 1 times.
How Many Employees Does BioGaia B Have?
BioGaia B has 242 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.